In this issue of Urologic Clinics of North America, guest editor Dr. Steven A. Kaplan brings his considerable expertise to the topic of Current Medical and Surgical Treatments for Benign Prostatic Hyperplasia. Top experts explore evidence-based approaches, novel techniques, and outcomes that provide a holistic understanding of BPH management, sharing their clinical experience while also looking forward at how genetics and AI can impact BPH patient outcomes.
Do Genetics Predict Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia? Patient Work-Up in the Modern Workplace: Role of Remote and Non-Invasive Diagnostics Improving Patient Selection for BPH Medical and Surgical Therapy Through a Deeper Understanding of Prostate Cellular and Molecular Biology Artificial Intelligence in Benign Prostatic Hyperplasia Laser Enucleation Therapy for Benign Prostatic Hyperplasia Making Waves: An Update on Aquablation UroLift, Rezum, and iTind for Benign Prostatic Hyperplasia Balloons in Benign Prostatic Hyperplasia: Will They Float? A Comprehensive Review of Prostatic Balloon Prostatoplasty Novel Stent-like Devices for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Updates on Prostate Arterial Embolization Nocturia in Men: Is the Prostate Really to Blame? Medical Therapy for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms Review of Current Guidelines and Innovations in Benign Prostatic Hyperplasia Evaluation and Management Benign Prostatic Hyperplasia Procedures in Patients with Prostate Cancer: What Do We Know?
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.